Clinical Edge Journal Scan

Osteophytes are the most common lesions in PsA patients receiving bDMARD


 

Key clinical point: A substantial proportion of patients with psoriatic arthritis (PsA) who received biological disease-modifying antirheumatic drug (bDMARD) therapy showed osteoproliferative lesions on a lumbar radiograph, with osteophytes being the most common.

Major finding: Osteophytes were the most common lesions and were detected in 42.3% of patients, with 18.1% of patients being diagnosed with grade ≥2 osteophytes. At least one syndesmophyte was detected in 24.2% of patients, with 9.3% and 19.8% of patients showing bridging and corner syndesmophytes, respectively. Ambiguous lesions were detected in 7.1% of patients.

Study details: Findings are from an analysis of 182 patients with PsA who received bDMARD therapy and underwent lumbar radiography assessment.

Disclosures: This research was funded by Hacettepe Rheumatology Society, Turkey. The authors declared no conflicts of interest.

Source: Ayan G et al. Degenerative and inflammatory osteoproliferations in lumbar radiographs in psoriatic arthritis patients. J Clin Med. 2022;11(7):2009 (Apr 3). Doi: 10.3390/jcm11072009

Recommended Reading

Parents’ autoimmune diseases may affect children’s development
MDedge Rheumatology
Upadacitinib earns FDA approval for ankylosing spondylitis 
MDedge Rheumatology
Reduced-frequency methotrexate monitoring causes no harm
MDedge Rheumatology
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
MDedge Rheumatology
Severe infections often accompany severe psoriasis
MDedge Rheumatology
FDA approves topical tapinarof for plaque psoriasis
MDedge Rheumatology
Improved outcomes with 6-month secukinumab use in PsA
MDedge Rheumatology
Sex and BMI affect response to systemic PsA therapy
MDedge Rheumatology
PsA: Real-world efficacy, safety, and retention rate of secukinumab
MDedge Rheumatology
Site of infection linked to PsA onset regardless of pathogen
MDedge Rheumatology